Mirabito Colafella lab publications
Selected highlight publications
1. Mirabito Colafella KM, Neves KB, Montezano AC, Garrelds IM, van Veghel R, de Vries R, Uijl E, Baelde HJ, van den Meiracker AH, Touyz RM, Danser AHJ, Versmissen J. Selective ETA versus dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats. Cardiovascular Research. 2019. In Press.
2. Uijl E*, Mirabito Colafella KM*, van Veghel R, de Vries R, Garrelds IM, Hoorn EJ, Poglitsch M, Kim J, Foster D, Danser AHJ. Long lasting RNA interference targeting angiotensinogen induces a robust and durable antihypertensive effect. Hypertension. 2019. 73(6):1249-1257. *Joint first authors.
3. Hitzerd E, Broekhuizen M, Mirabito Colafella KM, Glisic M, de Vries R, Koch BCP, de Raaf MA, Schoenmakers S, Reiss IKM, Danser AHJ, Simons SHP. Placental transfer and effects of sildenafil in healthy and preeclamptic conditions: focus on the nitric oxide pathway. EBioMedicine. 2019. 45:447-455.
4. Mirabito Colafella KM, Denton KM. Sex specific differences in the mechanisms of hypertension and associated cardiovascular diseases. Nature Reviews Nephrology. 2018. 14(3):185-201.
5. Mirabito Colafella KM, Samuel CS, Denton KM. Relaxin contributes to the regulation of arterial pressure in adult female mice. Clinical Science. 2017. 131(23): 2795-2805.
Additional publications
A full list of Mirabito Colafella Lab publications can be viewed on PubMed.